Does TOREMIFENE Cause Malignant neoplasm progression? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Malignant neoplasm progression have been filed in association with TOREMIFENE (Fareston). This represents 2.0% of all adverse event reports for TOREMIFENE.
5
Reports of Malignant neoplasm progression with TOREMIFENE
2.0%
of all TOREMIFENE reports
1
Deaths
1
Hospitalizations
How Dangerous Is Malignant neoplasm progression From TOREMIFENE?
Of the 5 reports, 1 (20.0%) resulted in death, 1 (20.0%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOREMIFENE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does TOREMIFENE Cause?
Fatigue (19)
Drug ineffective (17)
General physical health deterioration (14)
Atrial fibrillation (13)
Nausea (12)
Endometrial hyperplasia (10)
Hepatic function abnormal (10)
Oedema peripheral (10)
Drug-induced liver injury (9)
Endometrial thickening (9)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which TOREMIFENE Alternatives Have Lower Malignant neoplasm progression Risk?
TOREMIFENE vs TORIPALIMAB
TOREMIFENE vs TORSEMIDE
TOREMIFENE vs TOVIAZ
TOREMIFENE vs TOVORAFENIB
TOREMIFENE vs TOZINAMERAN